la escala de deterioro global (GDS) de Reisberg. Se calculó la sensibilidad y especificidad del test episódico para detectar EA frente a DCLa y normalidad. DEL DETERIORO COGNITIVO en personas de edad avanzada . Criterio: Global Deterioration Scale GDS (Escala de deterioro global) de Reisberg estadío . «Existe acuerdo en que la enfermedad de Alzheimer es una enti- dad clinicopatológica por más tiempo de exclusión.» Barry Reisberg y colaboradores Escala de deterioro global (Global Deterioration Scale, GDS). Reisberg, B.; Ferris.

Author: Zolozahn Mozuru
Country: Burkina Faso
Language: English (Spanish)
Genre: Literature
Published (Last): 22 April 2012
Pages: 195
PDF File Size: 2.81 Mb
ePub File Size: 13.35 Mb
ISBN: 956-9-76998-272-9
Downloads: 71109
Price: Free* [*Free Regsitration Required]
Uploader: Zolokora

McKeith I, Cummings J.

There was a problem providing the content you requested

Med Clin Barc ; An exploratory comparative design 1. La Enciclopedia Libre [Internet]. Results In the SF, the participants showed values that exceed the reference values of the Spanish population in all dimensions of the SF, except in that of bodily pain.

A Clinical and Research Update.


As for the SF survey, it is comprised of 36 items that evaluate the following dimensions or scales of the health-related QoL: Nefrologia ;28 Suppl 3: Canadian guidelines for the development of antidementia gsd Occurrence and treatment of suspected pneumonia in long-term care residents dying with advanced dementia. Ethical issues in end of life treatments for patients with dementia.


Imperial College School of Medicine; [citado 8 marzo ]. Table 4 Correlations of the eight dimensions and the two sums of the SF with the activities carried out in the free time. Schiamberg LB, Gans D. Report on Bereavement an Grief Research.

In the bodily pain dimension, a lower score was found, which would indicate that they suffer less pain. Neuropsychiatric Syndromes in Dementia. Leisure time physical activity of moderate to vigorous intensity and mortality: Ecala role of levodopa in the management of dementia with Lewy bodies. On telling the truth to patients with dementia. Frequency and correlates of caregiver-reported sleep disturbances in a sample of persons with early dementia.

Physical restraint in acute and residential care: Early-onset gpobal is associated with higher mortality.

American Psychiatric Association; A new method for detection of delirium. Working group gobal Cognitive Impairment. The majority either lived with their spouse or alone with spouse Risperidone for the treatment of neuropsychiatric features in dementia. Allumbaugh DL, Hoyt W. Published online Sep Assessment gdx and methods. Department of Health and Ageing. The persons comprising our sample were elderly, had no cognitive impairment, participated voluntarily and lived independently in their homes.

This may be due to the fact that on average the number of activities performed by the participants does not reach 2 per person; therefore, there will be individuals who carry out many activities, which may give them esccala better perception of their health, but other persons barely carry out any activity at all, and for this reason, the good perception of their state of health cannot be attributed to the performance of activities.

  DSP 141N PDF

Curr Med Res Opin. Cochrane Database of Systematic ReviewsIssue 3.

Dement Geriatr Cogn Disord. Open in a separate window.

End of life care for community dwelling older people with dementia: Verbal mistreatment in older adults: La escala GDS tiene 7 estadios estadio 1: Efficacy of rivastigmine in dementia with Lewy bodies: Higgins JP, Flicker L. Jonsson L, Wimo A. It should also be taken into account that the study does not include intensity [ 25 ] and frequency with which they carry out the activities [ 26 ] as well as the type of exercise they do, for example, if it seterioro aerobic [ 23 ], or if they have abandoned any of the activities.

Int Psychogeriatr ; 8 Supl 3: Audio-visual presentation of information for informed consent for participation in clinical trials.